Clinical Trial Update: Analgecine for Treatment of Low Back Pain [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Analgecine for low back pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Analgecine

Snippet

Sponsor: VanWorld Pharmaceutical (Rugao) Company Limited | Conditions: Low Back Pain | Phase 3 | Status: COMPLETED